Advisory Board

Our experts are highly respected authorities in the biosimilars and healthcare industries, including health economics experts, pharmacists, managed care professionals, and key clinical specialists. We are the authoritative resource for emerging therapies.

Ivo Abraham, PhD, RN

Director, Center for Health Outcomes and PharmacoEconomic Research
The University of Arizona Cancer Center

Joseph P. Fuhr, Jr., PhD

Professor Emeritus
Widener University

Christy M. Gamble, JD, DrPH, MPH

Director of Budget and Policy Advocacy, American Public Human Services Association

Erin Hohman, PharmD, BCPS

Director of Clinical Pharmacy Services
Amber Pharmacy

Julie M. Kennerly-Shah, PharmD, MS, MHA, BCPS

Assistant Director
The James Cancer Hospital
The Ohio State University Medical Center

Jim M. Koeller, MS

Eli Lilly & C.R. Sublett Fellow
Professor of Pharmacotherapy
Pharmacotherapy Education & Research Center
University of Texas Health Science Center San Antonio

Molly Billstein Leber, PharmD, BCPS, FASHP

Medication Policy and Formulary Management
Yale New Haven Health System

Brian Lehman, MBA, MHA, RPh

Medical Account Management and Strategic Alliances

Rick Lozano

Vice President
Biosimilars and Integrated Business Development

Steven Lucio, PharmD, BCPS

Associate Vice President
Clinical Solutions and Pharmacy Program Development

Julie Marechal-Jamil

Biosimilars Policy and Science
Medicines for Europe

Ali McBride, PharmD, MS, BCPS

Clinical Coordinator Hematology/Oncology
The University of Arizona Cancer Center

Sonia T. Oskouei, PharmD

Director of Pharmacy Program Development - Biosimilars
Premier Inc

Kashyap Patel, MD

Medical Oncologist
Carolina Blood and Cancer Care

Leigh Purvis, MPA

Director, Health Services Research
AARP Public Policy Institute

Ronald A. Rader

Biotechnology Information Institute

Hope Rugo, MD

Clinical Professor
Department of Medicine (Hematology/Oncology)
Breast Oncology Clinical Trials Program
University of California at San Francisco

Gregory F. Schimizzi, MD

Carolina Arthritis Associates

Kyle F. Skiermont, PharmD

Fairview Pharmacy Services

Marcus Snow, MD

Assistant Professor of Internal Medicine
Division of Rheumatology
University of Nebraska Medical Center

James G. Stevenson, PharmD, FASHP

Department of Clinical Pharmacy
University of Michigan College of Pharmacy

Ha Kung Wong, JD

Fitzpatrick, Cella, Harper & Scinto

If you are interested in becoming a contributor and adding your voice to the conversation, contact our Associate Editorial Director or our Senior Editor.

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2018 Intellisphere, LLC. All Rights Reserved.